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Cardiac Magnetic Resonance 
Elen Elen, Celly A Atmadikoesoemah, Manoefris Kasim
Background: Left ventricular (LV) dysfunction was frequently found in rheumatic mitral 
stenosis. Myocardial fibrosis had been revealed in rheumatic heart disease and could be 
associated with LV dysfunction. We evaluate myocardial fibrosis profile related to LV 
function in rheumatic mitral stenosis with cardiac magnetic resonance (CMR). 
Methods: Eighteen patients with severe rheumatic mitral stenosis without history 
of coronary artery disease or its risk factors underwent 1.5T CMR examination. LV 
ejection fraction (LVEF), right ventricular ejection fraction (RVEF), myocardial fibrotic 
tissue were evaluated with CMR. Other hemodynamic data was derived from echocar-
diography results. 
Results: These patients (40.4±10.5 years old, 72.2% female, 66.7% atrial fibrillation) 
had LVEF of 50.9±15.9% and RVEF of 37.7±13.9%. Volume of fibrotic tissue in these 
patients were 16.6 (5.5-55.8)%. In multivariate analysis, volume of fibrotic tissue was a 
significant predictor of LVEF that myocardial fibrotic tissue of 1% was associated with 
LVEF reduction of 0.87% (95% CI 0.51%-1.24%). 
Conclusion: LV function was determined by the extent of myocardial fibrosis in rheu-
matic mitral stenosis.
(Indonesian J Cardiol. 2017;38:202-6)
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Latar Belakang: Disfungsi ventrikel kiri (LV) sering ditemukan pada mitral stenosis rematik. Fibrosis miokardium ditemukan pada penyakit 
jantung rematik. Fibrosis miokardium pada penyakit jantung rematik juga dihubungkan dengan disfungsi LV. Kami mengevaluasi profil fibrosis 
miokardium yang berhubungan dengan fungsi LV pada mitral stenosis rematik dengan cardiac magnetic resonance (CMR).
Metode: Dilakukan pemeriksaan 1.5T CMR pada delapanbelas pasien dengan mitral stenosis rematik berat tanpa riwayat penyakit jantung 
koroner atau faktor resikonya. Fraksi ejeksi LV (LVEF), fraksi ejeksi RV (RVEF), dan jaringan fibrotik miokardium dievaluasi menggunakan 
CMR. Data hemodinamik lainnya didapatkan dari pemeriksaan ekokardiografi. 
Hasil: Pasien tersebut (40.4±10.5 tahun, 72.2% perempuan, 66.7% fibrilasi atrium) memiliki LVEF 50.9±15.9% dan RVEF 37.7±13.9%. Vol-
ume jaringan fibrotic pada pasien tersebut adalah 16.6 (5.5-55.8)%. Dalam analisis multivariat, volume jaringan fibrotic adalah prediktor LVEF 
yang signifikan yaitu 1% jaringan fibrotic miokardium dihubungkan dengan menurunan LVEF sebesar 0.87% (95% CI 0.51%-1.24%). 
Kesimpulan: Fungsi LV dipengaruhi seberapa besar fibrosis miokardium pada mitral stenosis rematik
(Indonesian J Cardiol. 2017;38:202-6)
Kata Kunci: fibrosis miokardium, disfungsi ventrikel kiri, mitral stenosis rematik
Pengaruh Fibrosis Myocardium terhadap Fungsi Ventrikel 
Kiri pada Stenosis Mitral Rematik: Studi Preeleminer 
dengan Cardiac Magnetic Resonance
Elen Elen, Celly A Atmadikoesoemah, Manoefris Kasim
Departemen Kardiologi dan Kedokteran Vaskular, Fakultas 
Kedokteran, Universitas Indonesia. Pusat Jantung Nasional Harapan 
Kita, Jakarta, Indonesia
Correspondence:
dr. Celly Atmadikoesoemah, Sp.JP, Department of Cardiology and 
Vascular Medicine, Faculty of Medicine, Universitas Indonesia. 
National Cardiovascular Center Harapan Kita, Jakarta, Indonesia. 
Email: idocelly@gmail.com
Background
Rheumatic heart disease (RHD) is a chronic inflamma-
tory disease that also involving myocardium. Left 
ventricular (LV) dysfunction was found in about 
one-fourth of patients with rheumatic mitral stenosis. 
Many theories were proposed as the causes of the LV 
dysfunction. Myocardial fibrosis had been revealed 
in rheumatic heart disease and could be associated 
with LV dysfunction.1 This study aimed to evaluate 
myocardial fibrosis profile related to left ventricular 
(LV) function in rheumatic mitral stenosis with cardiac 
magnetic resonance (CMR).
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Figure 1. Myocardial fibrotic tissue in severe rheumatic mitral stenosis with predilection 
  
 
Figure 2. Correlation between volume of fibrotic tissue and left ventricular ejection 
fraction  
i ure 1. Myocardial fibrotic tissu  in severe rheumatic 
mitral stenosis with predilection at inferior and anterior 
LV-RV junction
± SD while abnormal distribution data were expressed 
as median (minimum-maximum value). For categorical 
data, the proportion were expressed as percentage. The 
differences of proportion were analysed with Fischer’s 
exact test. The bivariate correlations were analyzed by 
Pearson correlation if the data were normally distributed 
and by Spearman correlation if the data were abnormally 
distributed. The multivariate analysis for LVEF was 
done by linier regression analysis. A value of p < 0.05 
was considered significant.
Results
These patients (40.4±10.5 years old, 72.2% female, 
66.7% atrial fibrillation) had mitral valve area of 
0.7±0.2 cm2, mean mitral valve gradient of 12.6±4.1 
mmHg. Severe pulmonary hypertension was observed 
in 66.7% patients. From CMR analysis of these 
patients, LVEF was 50.9±15.9% while RVEF was 
37.7±13.9%. 
Myocardial fibrotic tissue was found in all patients 
with distribution as follows: at basal and mid segments 
100%, at apical segments 55.6%. Fibrotic tissue at 
apical segments was observed more often in patients 
with LVEF < 50% (p 0.02). Fibrotic tissue was found 
at anterior 77.8%, septal 88.9%, lateral 88.9%, and 
inferior 94.4%, with predilection at inferior and 
anterior LV-RV junction (Figure 1). 
Methods
Study population
Eighteen patients with severe rheumatic mitral stenosis 
without history of coronary artery disease or its risk 
factors were prospectively enrolled in the period from 
August 2015 to March 2016 in National Cardiovascular 
Center Harapan Kita, Jakarta-Indonesia.  
Cardiac magnetic resonance examination
Cardiac magnetic resonance examination was done 
with using 1.5T MR scanner (Achieva, Philips Health-
care, Best, The Netherlands) with 32-channel cardiac 
coil. LV ejection fraction (LVEF) and right ventricular 
ejection fraction (RVEF) were quantified from cine-
CMR images using a sense balanced turbo field echo 
sequence with breath-hold. Myocardial fibrotic tissue 
were evaluated with late gadolinium enhancement 
(LGE) images. LGE images were done by using gapless 
whole heart coverage of short axis slices, 2-chamber 
and 4-chamber long axis slices and using gadobutrol 
(Gadovist®, Bayer, Leverkusen, Germany) with dose of 
0.1 mmol/kg body weight, then the image acquisition 
was done 10 minutes after contast administration. 
LVEF and RVEF were derived by end diastolic 
volume and end systolic volume. Endocardial borders 
were manually traced at end-diastole and end-systole 
phases from short axis slices. The papillary muscles 
were included as part of the LV cavity volume. LGE 
was quantified by a manual contouring method 
and reported as a percentage of total LV mass. 
Postprocessing analysis were done by using commercial 
software (CVI42®, Circle, Calgary, Canada).
Other hemodynamic data
Mitral valve area, mean mitral valve gradient, 
severity of pulmonary hypertension were obtained 
by echocardiography examination that were done 1-2 
weeks before CMR examination.
Statistical analysis 
Statistical analysis was performed using dedicated soft-
ware (IBM SPSS Statistics, version 22). Shapiro-Wilk 
test and histograms were preliminarily performed to 
assess distribution of quantitative data. For numerical 
data, normal distribution data were expressed as mean 
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Figure 2. Correlation between volume of fibrotic tissue and left ventricular 
ejection fraction
  
 
Figure 1. Myocardial fibrotic tissue in severe rheumatic mitral stenosis with predilection 
  
 
Figure 2. Correlation between volume of fibrotic tissue and left ventricular ejection 
fraction  
Volume of fibrotic tissue in these patients were 16.6 
(5.5-55.8)%. In bivariate analysis, volume of fibrotic 
tissue had strong negative correlation with LVEF (r 
-0.95, p<0.001) as seen in Table 1 and Figure 2. By 
multivariate analysis, volume of fibrotic tissue was a 
significant predictor of LVEF. Myocardial fibrotic tissue 
volume of 1% was associated with LVEF reduction of 
0.87% (95% CI 0.51-1.24%).
Discussion
Chronic rheumatic heart disease had a persistent 
inflammatory process in the heart tissue in the absence 
of the infectious agent. The inflammatory process can 
be characterized by typical Aschoff bodies and has a 
predilection for the heart valves. It is characterized by 
deforming fibrotic valvular disease, especially as mitral 
stenosis.2 In addition to affecting the cardiac valves, 
rheumatic heart disease is a pancarditis affecting to various 
Table 1. Bivariate analysis for left ventricular ejection fraction
Variabel r p
Age (years old) 0.05 0.83
Gender 0.71
Heart rhythm - AF 0.08
Mitral valve area (cm2) -0.16 0.52
Pulmonary hypertension 0.82
RVEF (%) 0.49 0.04
Volume of fibrotic tissue (%) -0.95 <0.001
AF=atrial fibrillation, RVEF=right ventricular ejection fraction
Table 2. Multivariate analysis for left ventricular ejection fraction
Variable B β p 95% 
Confidence interval
(Constant)
Volume of fibrotic tissue
Heart rhythm - AF
RVEF
66.39
-0.87
-2.41
0.13
-0.81
-0.07
0.11
<0.001
<0.001
0.61
0.45
49.02 – 83.78
-1.24 - -0.51
-12.42 – 7.60
-0.23 – 0.49
AF=atrial fibrillation, RVEF=right ventricular ejection fraction
degrees the endocardium, myocardium, and pericardium. 
In some cases, rheumatic myocarditis results in cardiac 
dilation and progressive heart failure. LV dysfunction was 
found in one fourth of patients with pure mitral stenosis. 
Several pathophysiologic theories of LV dysfunction in 
rheumatic MS has been proposed, such as: underflow 
preload, altered interaction between right and left ventricles, 
rhythm disturbance, and myocardial fibrosis.1
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Myocardial fibrosis is a common sequelae of 
rheumatic fever and can be associated with LV 
dysfunction. Interstitial fibrosis and myocyte disarray 
were found as microscopic findings of myocardium 
in delayed-enhanced segments by CMR, while no 
evidence of myocardial fibrosis was found in non-
delayed-enhanced segments.3 Most RHD patients with 
severe LV dysfunction but no evidence of myocardial 
fibrosis in LGE-CMR could have LV function 
improvement after valve surgery.4 
This study revealed myocardial fibrotic tissue in 
rheumatic severe mitral stenosis patients. The distribution 
was more rare in apical segments rather than basal-mid 
segments (closer segments to mitral valve). Patient with LV 
dysfunction had more fibrotic tissue in apical segments, this 
could indicate more severity of the disease.  The fibrotic 
tissue was distributed evenly at anterior, septal, lateral, 
and inferior segments. Volume of fibrotic tissue negatively 
correlated with LV systolic function. This quantification of 
myocardial fibrotic tissue in rheumatic mitral stenosis may 
contribute as prognostic factor prior to valve surgery. 
Conclusion
LV function in patients with rheumatic mitral stenosis 
was determined by the extent of myocardial fibrosis.
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